Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-07 @ 10:23 AM
Study NCT ID:
NCT00840203
Status:
COMPLETED
Last Update Posted:
2024-08-19
First Post:
2009-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mesalamine 4 gm/60 mL Rectal Enema
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-05
Start Date Type:
None
Primary Completion Date:
2003-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-06
First Submit QC Date:
None
Study First Post Date:
2009-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-06-30
Results First Submit QC Date:
None
Results First Post Date:
2009-08-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-15
Last Update Post Date:
2024-08-19
Last Update Post Date Type:
ACTUAL